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Introduction: Surface modification of titanium (Ti) implants promotes bone formation and shortens the
osseointegration period. The aim of this study was to promote bone regeneration and stability around implants
using atmospheric pressure plasma (APP) pretreatment. This was followed by immobilization of stem cells from
human exfoliated deciduous teeth-conditioned medium (SHED-CM) on the Ti implant surface.
Methods: Ti samples (implants, discs, powder) were treated with APP for 30 seconds. Subsequently, these were
immobilized on the treated Ti surface, soaked and agitated in phosphate-buffered saline or SHED-CM for 24 hours
at 37 °C. The surface topography of the Ti implants was observed using scanning electron microscopy with energy
dispersive X-ray spectroscopy. In vivo experiments using Ti implants placed on canine femur bone were then
conducted to permit histological analysis at the bone-implant boundary. For the in vitro experiments, protein assays
(SDS-PAGE, Bradford assay, liquid chromatography-ion trap mass spectrometry) and canine bone marrow stromal
cell (cBMSC) attachment assays were performed using Ti discs or powder.
Results: In the in vitro study, treatment of Ti implant surfaces with SHED-CM led to calcium phosphate and
extracellular matrix protein immobilization. APP pretreatment increased the amount of SHED-CM immobilized on
Ti powder, and contributed to increased cBMSC attachment on Ti discs. In the in vivo study, histological analysis
revealed that the Ti implants treated with APP and SHED-CM stimulated new bone formation around implants.
Conclusions: Implant device APP pretreatment followed by SHED-CM immobilization may be an effective application
to facilitate bone regeneration around dental implants.Introduction
Titanium (Ti) implants are widely used for the restoration
of missing teeth. However, Ti by itself does little to pro-
mote new bone formation on the surface of the Ti implant.
This bone formation process, known as osseointegration,
delays implant loading and tends to increase implant sur-
vival time. Moreover, bone-implant contact (BIC) is the* Correspondence: t-shuhei@med.nagoya-u.ac.jp
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high BIC value indicates greater implant stability. How-
ever, there are a number of problems with current im-
plantation methods. First, it takes several months to obtain
sufficient implant stability. Second, bone morphogenesis is
often limited around the Ti implant [1]. New biomaterials
are therefore required to shorten the osseointegration
period and promote BIC [2, 3].
Studies have shown that osseointegration can be modu-
lated by implant surface properties [4]; for example, rough
surfaces promote osseointegration more effectively thanticle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in
operly credited. The Creative Commons Public Domain Dedication waiver
/1.0/) applies to the data made available in this article, unless otherwise stated.
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to modify implant surface properties. Mechanical and
chemical treatments such as sand blasting and acid
etching [6], anodization [7, 8], or hydroxyapatite coating
[9, 10] are used to modify the surfaces of Ti implants [11],
promoting osteogenesis and thus early osseointegration.
In addition to these mechanical and chemical treatments,
hydrophilic treatments such as atmospheric pressure
plasma (APP) treatment [12–14], UV treatment [15] and
hydrothermal treatment [16] have also been used to obtain
early osseointegration. The effect of these hydrophilic
treatments is protein immobilization promotion as a result
of hydrocarbon removal from the Ti surface [17].
Researchers have even recently attempted to engraft
bone marrow stromal cells (BMSCs) or umbilical cord
stem cells onto the implant surface to improve osseoin-
tegration [18, 19]. The methods used for cell engraft-
ment, however, were complicated, and resulted in poor
cell differentiation and survival rates [20]. Biological
molecules such as BMP-2 [21], type I collagen [22], fi-
bronectin [23], amelogenin [24], and an RGD peptide
[25] were then added along with the stem cell implant to
try and better simulate the microenvironment of bone
and promote osseointegration [26].
We have previously attempted to build on these sur-
face modification approaches by immobilizing mesen-
chymal stem cell-conditioned medium (MSC-CM) on
the implant surface. Conditioned medium (CM) is a po-
tentially useful tool for stimulating bone regeneration
because cultured MSCs secrete various growth factors
and cytokines into the medium that have the capability
of stimulating tissue regeneration [27, 28]. CM offers a
convenient method to promote tissue regeneration/heal-
ing because it is easy to obtain large quantities of this
medium with uniform quality [29–31]. We previously
reported that immobilization of CM derived from
BMSCs on Ti implants promoted osteogenesis around
the implant, and contributed to early stability after im-
plantation [32]. CM derived from BMSCs contains cyto-
kines, growth factors, and extracellular matrix (ECM)
components [33] that play important roles in the regen-
eration of bone around the Ti implants. Recently, stem
cells from human exfoliated deciduous teeth (SHED)
were used for bone regeneration [34]. SHED are a popula-
tion of highly proliferative postnatal stem cells capable of
differentiating into odontoblasts, adipocytes, neural cells,
and osteogenic cells [35]. Additionally, SHED have a higher
capacity to undergo differentiation than bone marrow-
derived mesenchymal stem cells [36, 37]. We hypothesized
that APP pretreatment followed by immobilization of
SHED-conditioned medium (SHED-CM) on the surface of
the Ti implant may promote osteogenesis around the
implant, thus facilitating early osseointegration. To investi-
gate this hypothesis, SHED-CM from cultured exfoliateddeciduous teeth-derived cells was immobilized on a com-
mercially available Ti implant pretreated with APP. The
components of biomolecules in the SHED-CM immobi-
lized on the surface of pretreated Ti implants, the initial at-
tachment of canine bone marrow stromal cells (cBMSCs)
to the Ti discs, and the stability of the Ti implants after im-
plantation into dog femurs were analyzed. We demonstrate
that APP pretreatment increases the amount of SHED-
CM-derived proteins immobilized on the implant surface,
and promotes the attachment of cBMSCs onto the Ti sur-
face, thereby contributing to early osseointegration.
Methods
Ti materials
A Brånemark MK III TiUnite® threaded external hex
(diameter 3.75 mm, length 7 mm; Nobel Biocare,
Gothenberg, Sweden) was used in our experiments. Pure
grade I Ti discs (diameter 15 mm) were purchased from
Ofa Co. Ltd (Chiba, Japan). Ti powder (1–2 mm particle
size) was obtained from Rare Metallic Co. Ltd (Tokyo,
Japan).
Cell culture
Human dental pulp tissues were obtained from clinically
healthy, extracted deciduous teeth from patients aged 6–
12 years old. The consents were obtained from all patients
to establish SHED samples. The Nagoya University Ethics
Committee approved the experimental protocols from
ethical and scientific points of view. The SHED were a gift
from Kiyoshi Sakai [38]. cBMSCs were isolated from the
aspirated iliac bone marrow of hybrid dogs (18–36
months old, weight 15–25 kg). The single cell suspension
of dental pulp/canine iliac bone marrow was seeded onto
culture dishes. The dishes were then cultured at 37 °C and
5 % CO2 in Dulbecco’s modified Eagle’s medium (DMEM;
Sigma-Aldrich, St. Louis, MO, USA), and supplemented
with 10 % fetal bovine serum (FBS; Gibco, Rockville, MD,
USA). Further, 1 % antibiotic-antimycotic (100 units/mL
penicillin G, 100 mg/mL streptomycin, and 0.25 mg/mL
amphotericin B; Gibco) was added to the culture. After
3 days of culture, floating cells were removed and the
medium was replaced with fresh medium. Subsequently,
the medium was changed once every 2 days. Spindle-
shaped cells that adhered onto the plastic dish were pas-
saged when the cells approached confluence using 0.05 %
trypsin-EDTA (Gibco). The cells belonging to passages 3–
9 were used for experiments as the SHED or cBMSCs.
Preparation of SHED-CM
SHED-CM was prepared in accordance with published
methods [39]. The cell culture medium was changed to
serum-free DMEM after SHED reached 70–80 % conflu-
ence. After 48 hours incubation at 37 °C and 5 % CO2,
the culture medium was collected and centrifuged at
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centrifugation at 44,280 × g for 3 minutes at 4 °C, the
supernatant was collected and was used as SHED-CM.
APP treatment on Ti materials
The implants were treated with APP using a system
power of 400 W with N2 gas (MPS-01K01C, Kurita fac-
tory Co. Ltd Japan). The distance between the plasma
pen (the end of the discharge capillary) and implant was
set at 5 mm. The length of the free-burning plasma
plume was 10 mm, and the plasma treatment time was
30 s. Ti powder and Ti discs were treated using the same
method.
Immobilization of SHED-CM on Ti materials
Immediately after APP treatment, Ti samples were soaked
and agitated in SHED-CM for 24 hours at 37 °C. As a con-
trol, plasma-treated and plasma-untreated Ti samples
were soaked and agitated in phosphate-buffered saline
(PBS). After treatment, the Ti materials were washed three
times with 10 mL PBS. Samples were then divided into
four groups: the plasma-untreated Ti on which PBS was
immobilized (N-PBS), plasma-treated Ti on which PBS
was immobilized (P-PBS), plasma-untreated Ti on which
SHED-CM was immobilized (N-CM), and plasma-treated
Ti on which SHED-CM was immobilized (P-CM).
Characterization of the Ti implant surface
Implant samples were prepared according to standard
procedure. Briefly, a 30-μm thick osmium coating was ap-
plied to the surface of Ti materials with an osmium
plasma coater (NL-OPC80NS; Japan laser electron Co.
Ltd, Tokyo, Japan). The surface topography of the Ti im-
plant was examined by scanning electron microscopy
(SEM) (S-800S; Hitachi High-Technology, Tokyo, Japan)
alone, and SEM (S-4800; Hitachi High-Technology) com-
bined with energy dispersive X-ray spectroscopy (SEM-
EDX) (HORIBA-EMAX80; Hitachi High-Technology).
Imaging was performed at 10 kV and 3.3 A. N-CM im-
plants were treated with 4 M guanidine (Sigma-Aldrich)
or 10 % EDTA (Sigma-Aldrich) for 15 minutes at 37 °C.
These N-CM implants were then observed using SEM-
EDX with identical parameter settings to CM implants.
Protein assay
Proteins in SHED-CM immobilized on 30 g Ti powder
were extracted with distilled water, 4 M guanidine, or
10 % EDTA. The extracts were dialyzed for 5 days in a
Visking tube (Nihon Medical Science Co. Ltd, Osaka,
Japan) against 7.5 L distilled water. The samples were fro-
zen and then dried using a FreeZone Freeze Dry System
(FZ-1; LABCONCO, Kansas, MO, USA). Proteins
extracted using 4 M guanidine were quantified using a
Bradford protein assay [40] and then analyzed by 10 %SDS-PAGE. This protein analysis was then followed by
silver staining (Pierce® Color Silver Stain Kit; Thermo
Scientific, Rockford, IL, USA) and Coomassie Brilliant
Blue (CBB) staining according to standard procedure. The
extracted proteins and an undiluted solution of SHED-CM
were analyzed using liquid chromatography-ion trap mass
spectrometry (LC/MS/MS). In-solution protein digestion
was carried out through alkylation, demineralization, and
concentration steps in order to prepare proteins for LC/
MS/MS analysis. In the alkylation step, samples were
mixed with 7 M guanidine hydrochloride (WAKO Pure
Chemical Industries, Osaka, Japan) in distilled water. To
this solution, 20 μL of 3 M Tris-HCl (pH 8.5) and 10 μL of
0.1 M DTT (WAKO Pure Chemical Industries) were
added. The mixture was then allowed to stand for 30 mi-
nutes at room temperature. Following this, 10 μL of 0.2 M
iodoacetamide (WAKO Pure Chemical Industries) was
added, and the mixture was incubated for 1 hour at room
temperature in the dark. In the demineralization and con-
centration steps, chloroform methanol precipitation was
performed. In the last step, a trypsin digest was performed
for 16 hours at 37 °C with 10 μL urea, 40 μL of 0.1 M Tris-
HCl (pH 8.5), and 0.5 μL of 1 μg/μL Trypsin Gold for MS
(Promega KK, Tokyo, Japan) diluted in 50 mM acetic acid
(WAKO Pure Chemical Industries). After digestion, sam-
ples were centrifuged at 20,000 × g for 20 minutes at 4 °C,
and the middle layer containing proteins in three layers
was collected. Nanoelectrospray tandem mass spectromet-
ric analysis was then performed using an LCQ Advantage
mass spectrometry system (Thermo Finnigan, Waltham,
MA, USA) in series with a Paradigm MS4 HPLC System
(Michrom BioResources, Auburn, CA, USA). Samples were
injected onto the Paradigm MS4 HPLC System equipped
with a Magic C18AQ column (diameter 0.1 mm, length
50 mm; Michrom BioResources). Reverse-phase chroma-
tography was performed by applying a linear gradient (0
minutes, 95 % A and 5 % B; 45 minutes, 0% A and 100 %
B) of solvent A (2 % acetonitrile with 0.1 % formic acid)
and solvent B (90 % acetonitrile with 0.1 % formic acid) at a
flow rate of 1 μL/minute. Ionization for mass spectrometry
was performed using an ADVANCE Captive Spray Source
(Michrom BioResources) at a capillary voltage of 1.6 kV
and a temperature of 150 °C. Prior to MS/MS analysis, a
precursor ion scan was carried out using a 400 to 2,000
mass to charge ratio (m/z). Multiple MS/MS spectra were
submitted to the Mascot program, version 2.4.1 (Matrix
Science, Boston, MA, USA) for the MS/MS ion search.
Cell attachment assay
The cBMSCs (1.0 × 105) were seeded on treated Ti discs
(n = 3) and cultured at 37 °C and 5 % CO2 for 1 or
24 hours. The cBMSCs that adhered to Ti discs were re-
moved using incubation with 0.05 % Trypsin-EDTA
(Gibco) for 5 minutes. Ti discs were examined to ensure
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were counted with the help of a hemocytometer (Sunlead
Glass, Tokyo, Japan). After 24 hours, cultured cBMSCs
were fixed with 4 % paraformaldehyde (Sigma-Aldrich)
and stained with desired fluorescent dyes followed by 100
nM DAPI (Roche Applied Science, Basel, Switzerland),
and 100 nM rhodamine phalloidin (Cytoskeleton, Inc.,
Denver, CO, USA) stains. After histological staining, the
cells were visualized using a confocal laser-scanning
microscope (A1+; Nikon, Tokyo, Japan).
In vivo experiments
All animal experiments were reviewed and approved in ad-
vance by the ethics committee of the Nagoya University
School of Medicine. Surgical procedures were performed
as reported previously [41]. Briefly, hybrid dogs (aged 18–
36 months, weight 15–25 kg) were operated under general
anesthesia induced by intravenous administration of pento-
barbital (Somnopentyl®; Kyoritsu Seiyaku, Tokyo, Japan)
used at 20 mg/kg body weight. Following hair shaving and
cleaning with iodine solution at the femur and surgical sur-
rounding area, a 5-cm incision was made at the skin level.
The flap was reflected and the radius diaphysis was ex-
posed. The initial drilling was performed using a 2-mm
diameter pilot drill at 2,000 rpm. Then, low-speed sequen-
tial drilling with burs of 2.4, 2.8, and 3.2 mm was per-
formed at 2,000 rpm, and the osteotomy sites were
unicortical defects. The procedure included irrigation with
cold saline during drilling to reduce the heat from friction.
A total of 32 implants (n = 4) was inserted into femurs,
1.5 cm apart, using a dental implant device (Implanter
Neo; Kyocera Medical, Osaka, Japan). The surgical wound
was then closed carefully with 4-0 absorbable surgical su-
ture (Atom vet’s medical, Kyoto, Japan). Post-surgical man-
agement involved intake of antibiotics (Azithromycin;
Pfizer, Tokyo, Japan) daily for 3 days, a soft diet, and
topical application of 2 % chlorhexidine (Dainippon
Sumitomo Pharma, Osaka, Japan) twice a week. At 4 or
8 weeks after the implantation, the dogs were given
general anesthesia and euthanized by exsanguination
following the administration of heparin sodium (400 U/kg)
and were perfused with 10 % formalin (WAKO Pure
Chemical Industries).
Radiological and histological analysis
Samples were visualized using a laboratory micro-CT
machine (R_mCT2; Rigaku Co., Tokyo, Japan). Three-
dimensional image-analysis software (TRI/3D-BON;
Ratoc System Engineering, Tokyo, Japan) was then used
to construct three-dimensional images of these samples.
Samples were then embedded in Technovit 7200®
(Okenshoji Co. Ltd, Tokyo, Japan) for histological ana-
lysis. Each block was cut along the long axis of the im-
plant into 30-μm thick sections. The sections werestained using 0.05 % toluidine Blue (Muto Chemical Co.
Ltd, Tokyo, Japan) according to standard methods. The
BIC and bone area fraction occupancy (BAFO) were an-
alyzed with published methods [12]. Digital images of
sections were analyzed with image-analysis software
(VMS-50 VideoPro®, Inotech Corporation, Hiroshima,
Japan) after computer-based histomorphometric mea-
surements. BIC (%) was estimated using the following
equation BIC (%) = direct implant bone contact/peri-
implant length. The BAFO between plateaus was de-
termined with the help of Image J (Ver.1.46 K; [42])
from confocal microscopy images. The percentage area
occupied by bone was calculated from the total area
within the implant thread.
Statistical analysis
Statistical differences were evaluated with the help of
Tukey’s HSD (honestly significant difference) test (IBM
SPSS statistics 21, Armonk, NY, USA). Digitized quantita-
tive of SHED-CM, counts of attached cells, BIC, and BAFO
have been expressed as means ± standard deviations. The
threshold for statistical significance was set at P < 0.05.
Results
Topographical characterization of the Ti implant surface
treated with APP and SHED-CM
The SEM images revealed differences between the treat-
ments on the Ti implant surface. Under × 10,000 magni-
fication, the surface of N-PBS and P-PBS showed only
projections of TiUnite®, with roughness of several mi-
crometer in thickness. In contrast, the N-CM and P-CM
surfaces showed attached round-shaped deposits (Fig. 1c,
d, g, h) that were uniformly distributed on the Ti im-
plants. Further, a greater abundance of attached deposits
in P-CM than in N-CM was observed. Under × 30,000
magnification, the deposits had an aggregated appearance.
Deposit diameter was approximately 350 nm. Additionally,
needle-shaped structures were visible at the interface of
the substrate and implant. SEM-EDX spectra of N-CM
and P-CM revealed the presence of calcium (Ca), carbon
(C), phosphate (P), oxide (O) and Ti, whereas those of N-
PBS and P-PBS showed the presence of only C, P, O and
Ti (Fig. 2a). X-ray mapping of SEM images revealed high
concentrations of Ca, C, P and O, and a low abundance of
Ti in the round-shaped deposits in the CM implants
(Fig. 2b).
Quantification and identification of proteins derived from
SHED-CM on the Ti surface
Results of SDS-PAGE analysis showed the presence of
protein in PBS and guanidine extracts from Ti pow-
der. In contrast, EDTA extracts did not contain any
detectable amounts of protein (Fig. 3a, b). Guanidine
is known to denature proteins and was used to extract
Fig. 1 Topology of Ti implant surface, analyzed using SEM. Under × 10,000 magnification (a-d); under × 30,000 magnification (e-h). (a, e)
Plasma-untreated Ti on which PBS was immobilized (N-PBS) implants, (b, f) plasma-treated Ti on which PBS was immobilized (P-PBS) implants,
(c, g) plasma-untreated Ti on which SHED-CM was immobilized (N-CM) implants, (d, h) plasma-treated Ti on which SHED-CM was immobilized
(P-CM) implants. Bars indicate 3 μm (a–d) and 1 μm (e–h)
Fig. 2 Characterization of Ti implant surface using SEM-EDX. SEM-EDX spectrum of the phosphate-buffered saline (PBS) group and stem cells from
human exfoliated deciduous teeth-conditioned medium (SHED-CM) group (a), and SEM images and X-ray mapping of elemental calcium (Ca),
carbon (C), oxide (O), phosphate (P), and titanium (Ti) of P-CM in the pink frame (b). Bar indicates 1 μm
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Fig. 3 Protein extraction of Ti surface and relationship between protein and Ca components. Coomassie Brilliant Blue (CBB) (a) and Stains All (b)
were used to stain the SDS-PAGE gel after loading the extracts of protein immobilized on titanium powder. Distilled water (DW), 4 M guanidine,
or 10 % EDTA was used for extraction. SEM images and SEM-EDX spectrum of 10 % EDTA (c) and 4 M guanidine (d). Bar indicates 1 μm. MW
Molecular weight, M Marker, O oxide, P phosphate, Ti titanium
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is a chelating reagent that removes Ca2+ and Mg2+
ions and was used to extract the Ca2+ component of
the Ti powder. After treatment with guanidine and
EDTA, a SEM-EDX spectrum of P-CM implant sur-
faces showed that Ca was absent on their Ti surfaces.
SEM images confirmed a lack of attached substances
(Fig. 3c, d). The results of silver staining of SDS-
PAGE gels showed immobilized proteins on Ti pow-
der and revealed higher amounts of protein in P-CM
than in N-CM (Fig. 4a). Results of the Bradford pro-
tein assay showed that the quantity of protein im-
mobilized on the Ti surface was significantly higher in
P-CM than in N-CM (Fig. 4b). LC/MS/MS analysis
identified the presence of various proteins in SHED-
CM (Table 1) and in the 4 M guanidine extracts of
treated Ti powder (Table 2). However, these proteins
were not found in the 10 % EDTA extracts (Table 3).
The proteins that attached to Ti primarily consisted
of ECM proteins such as collagen type I, fibronectin,
and decorin.Effect of APP and SHED-CM on the cBMSC attachment to
the Ti surface
The number of cells attached to the Ti discs was not sig-
nificantly different among the four experimental groups
after 1 hour in culture. However, after 24 hours in cul-
ture, the number of attached cells was significantly
higher in the P-CM groups than either the N-PBS or P-
PBS groups (Fig. 5a). Phalloidin and DAPI staining fur-
ther verified this observation by showing that the num-
ber of attached cells was higher in N-CM and P-CM
groups than in N-PBS and P-PBS (Fig. 5b–e). The
morphology of cBMSCs was similar in all experimental
groups.
Micro-CT analysis of implant treated with APP and SHED-
CM
Calcification around the implant fixture was evaluated
using micro-CT. Images collected 4 and 8 weeks after im-
plantation showed that radiopacities indicating calcified
tissue formation were greater in N-CM and P-CM than in
N-PBS (Fig. 6). Further, the opacity was significantly
Fig. 4 Quantification of protein derived from SHED-CM by using APP pretreatment. Silver staining of proteins separated by SDS-PAGE. Proteins
immobilized on titanium powder (N-CM and P-CM) were extracted using 4 M guanidine (a). Results of the Bradford protein assay (b). Data from
panel (b) are presented as mean ± SD (n = 3). *P < 0.05, **P < 0.01. M Marker, N-CM plasma-untreated Ti on which SHED-CM was immobilized,
N-PBS plasma-untreated Ti on which PBS was immobilized, P-CM Plasma-treated Ti on which SHED-CM was immobilized, P-PBS Plasma-treated Ti
on which PBS was immobilized
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groups, the radiopacities were observed not only around
the implant interface, but also at the sides away from im-
plants. In contrast, the bottom of the implant showed no
significant radiopacities in all groups.
Bone morphogenesis around the Ti implant
Histological analysis performed 4 weeks after implant-
ation showed continuous newly formed bone in P-CM
(Fig. 7d). In other groups, bone formation was sparsely
distributed around the implant fixture (Fig. 7a–c). Eight
weeks post-implantation, we found more continuous
newly formed bone in N-CM and P-CM groups than in
N-PBS and P-PBS groups (Fig. 7e–h).
BIC and BAFO were measured in trabecular bone for
quantitative histological analysis. No significant differ-
ences in BIC were observed between experimental
groups at 4 weeks. However, 8 weeks after implantation,
BIC was significantly higher in N-CM and P-CM groups
than in N-PBS and P-PBS groups. Further, BIC was
higher in P-CM than in N-CM (Fig. 7i). After 4 weeks of
implantation, BAFO was significantly higher in P-CM
and N-CM than in N-PBS or P-PBS groups. Further, at
8 weeks post-implantation, BAFO was significantly
higher in P-CM or N-CM than in N-PBS (Fig. 7j).
Table 2 Protein identified in stem cells from human exfoliated
deciduous teeth-conditioned medium immobilized to titanium;
extraction using 4 M Guanidine
Protein name Accession No. Sequence
Collagen alpha-2 (I) chain P02464 R.GEAGAAGPAGPAGPR.G
Fibronectin P02751 R.ESKPLTAQQTTK.L
Collagen alpha-2 (I) chain P02452 K.GLTGSPGSPGPDGK.T
Vimentin P08670 K.ILLAELEQLK.G
Decorin P07585 K.ILLAELEQLK.G
IGF-binding protein 7 Q16270 K.ITVVDALHEIPVK.K
Follistatin-rerated protein 1 Q12841 R.YVQELQK.H
Metalloproteinase inhibitor 1 P01033 K.GFQALGDAADIR.F
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A variety of biomolecules, including peptides, ECM pro-
teins, and growth factors, have been used for implant
surface modification [43]. Previous reports have shown
that these biomolecules promote osseointegration and
bone formation around the Ti implant. CM was there-
fore used for tissue regeneration as CM contains various
biomolecules [27]. We previously showed that the CM
biomolecules derived from BMSCs immobilized on the
Ti surface and promoted osseointegration [31]. In this
study, SHED-CM was immobilized on the surface of Ti
because SHED had a higher ability for bone regeneration
than BMSCs [33, 34]. APP treatment was used in this
study in order to immobilize soluble proteins like CM
onto Ti. Thus, we attempted to promote both bone for-
mation and osseointegration by using a combination of
SHED-CM and APP treatment.
The SEM images of Ti implant “Brånemark MkIII
TiUnite®” showed a roughness of several micrometers in
thickness (Fig. 1a, e). Further, the material was porous,
and had an oxide film containing phosphorus on the
surface that facilitated osseointegration [44, 45] . SEM
images of the implant surface after APP processing
showed no significant changes (Fig. 1b, f ). The result
showed that APP treatment did not alter the surface
structure of the Ti implant. The SEM images and EDX
analysis suggested that these deposits formed calcium
phosphate (Ca-P) because the Ca and P signals were
overlapping (Fig. 1c, d, g, h; Fig. 2a, b). In a previous
study, Ca-P was deposited for 1 hour in a pH 7.4 elec-
trolyte solution containing calcium ion and phosphate
ion, corresponded to the presence of bodily fluids on theTable 3 Protein identified in stem cells from human exfoliated
deciduous teeth-conditioned medium immobilized to titanium;
extraction using 10 % EDTA
Protein name Accession No. Sequence
ND ND ND
ND Not DetectedTi discs [46]. The phosphorous solution contained a
number of compounds including calcium chloride, com-
ponents of the basic medium in the SHED-CM, inor-
ganic salts such as monosodium phosphate and sodium
bicarbonate, the oxide film, and CO2. Calcium and phos-
phate deposition during the 24 hours incubation of Ti in
SHED-CM, at 37 °C and pH 7.45, led to precipitation of
inorganic compounds. On the other hand, deposits on
the Ti implant treated with DMEM were also observed
[32]. However, the morphology and the amount of de-
posits treated with DMEM were different from that for
the SHED-CM group. This finding suggests that the
mixture of inorganic and organic components in SHED-CM
form different morphologies.
The proteins derived from SHED-CM on Ti particles
were detected in the only guanidine extract by using
SDS-PAGE, EDX, and SEM analyses (Fig. 3a, b). On the
other hand, Ca-P components were not detected in the
guanidine and EDTA extract (Fig. 3c, d). These results
suggested that the proteins were immobilized directly
onto the Ti surface. Further, protein immobilization did
not require calcium involvement. In previous reports,
proteins containing glycosaminoglycan were adsorbed
through calcium [47]. However, calcium-binding pro-
teins, such as osteocalcin and bone sialoprotein, were
not detected in the EDTA extract in this study.
The results of LC/MS/MS showed that ECM proteins
were the main components of the CM derived from
SHED (Tables 1, 2 and 3). However, some of the cyto-
kine and growth factors in SHED-CM were different
from the CM derived from BMSCs [32]. Immobilization
of type I collagen on Ti has been reported as primarily
involving van der Waals forces and hydrogen bonds be-
tween the proline of type I collagen molecules and Ti
[48]. These reports agree with our results.
The results of the silver staining and Bradford protein
assay showed improved immobilization of proteins on the
Ti surface following APP pretreatment. In this study, only
Ti powder was used for analysis of CM component ad-
sorption. There were no remarkable differences in the
amount of protein attached to different types of Ti mate-
rials. Further, this attachment depends more on the surface
topology or chemical properties, such as hydrophilicity
treatment, than different types of Ti material [17, 49, 50].
Therefore, we consider the Ti powder to be an appropriate
carrier for the protein attachment assay. Within 4 weeks
of its initial fabrication, Ti goes through an aging process
where the hydrophilic surface of Ti becomes hydrophobic
[51]. This aging process is a result of organic matter ad-
sorption on the implant surface similar to hydrocarbon
adsorption. This aging process leads to negative effects
on osteoblast proliferation and differentiation because
hydrocarbon disturbs protein immobilization [17]. In-
creased protein adsorption on Ti decreased hydrocarbon
Fig. 5 Effect of APP and SHED-CM on cBMSC attachment to the Ti surface. The detached cBMSCs were counted with the help of a
hemocytometer (a). Data are presented as mean ± SD (n = 3). *P < 0.05, **P < 0.01. Confocal microscopy images of cBMSCs 24 hours after seeding
(b-e). DAPI for nuclei (blue) and rhodamine phalloidin for actin filaments (red). N-CM plasma-untreated Ti on which SHED-CM was immobilized,
N-PBS plasma-untreated Ti on which PBS was immobilized, P-CM Plasma-treated Ti on which SHED-CM was immobilized, P-PBS Plasma-treated Ti
on which PBS was immobilized
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removed this hydrocarbon, preventing aging. This is simi-
lar to the method that UV and hydrothermal treatments
utilize to prevent aging [52]. In addition, it was found that
the adsorption of fibronectin onto the Ti surface increased
under hydrophilic conditions [53, 54]. These results
suggested that the elimination of organic matter from the
Ti surface improved hydrophilicity and increased the
immobilization of proteins derived from SHED-CM on
the Ti surface. In a previous study, we analyzed the
localization of rat BMSC-CM immobilized on Ti implants
after implantation by in vivo imaging [32]. Fluorescence
signals were detected in the BMSC-CM-treated groups at
28 days post-implantation, and confirmed the localization
of BMSC-CM around Ti implants. Overall, fluorescence
signals gradually decreased in a time-dependent manner
in the BMSC-CM-treated groups. The existence of CM
was confirmed on Ti implants on day 28. These results
show that the proteins derived from SHED-CM on the Ti
implants function on neighboring cells for at least 28 days.
The number of cBMSCs attached to Ti discs increased
after 24 hours in the P-CM groups (Fig. 5). This was
likely due to the deposition of fibronectin and type I col-
lagen on the Ti surface in the P-CM groups as both typeI collagen and laminin-5 promote adhesion of hMSCs
[55]. Further, fibronectin is also known to promote cell
adhesion. The number of osteogenic cells immobilized
onto Ti increased when the surface was treated with fi-
bronectin [23]. On the other hand, the number of
cBMSCs attached to P-CM was not significantly higher
than the number of cBMSCs attached to N-CM. This re-
sult meant that the quantity of protein immobilized on
the Ti disc did not impact cell attachment. SEM and
EDX analysis suggested that the ECM area was partially
covered by Ca-P. This meant that the ECM area avail-
able for cell attachment was no different from the ECM
area available in the N-CM groups. Further investigation
is warranted to utilize these ECM components more ef-
fectively. In this study, APP treatment did not signifi-
cantly improve cell attachment in both the PBS and
SHED-CM groups. It has previously been shown that
hydrophilicity treatment improves fibronectin adsorption
from serum, thereby promoting cell attachment [17].
We considered the possibility that components of PBS
(i.e., primarily Na+ or Cl−) bound to the substrate and
inhibited fibronectin adsorption in the P-PBS groups.
On the other hand, the surface area of Ti discs with
immobilized SHED-CM was similar in the P-CM and
Fig. 6 Micro-CT images of Ti implants inserted into the canine’s femur bone in vivo. X-ray images of bone formation around the Ti implants
4 weeks after implantation (a–h) and 8 weeks after implantation (i–p). (a, e, i, m) N-PBS implants; (b, f, j, n) P-PBS implants; (c, g, k, o) N-CM
implants; (d, h, l, p) P-CM implants. Bar indicates 5,000 μm. N-CM plasma-untreated Ti on which SHED-CM was immobilized, N-PBS plasma-untreated Ti
on which PBS was immobilized, P-CM Plasma-treated Ti on which SHED-CM was immobilized, P-PBS Plasma-treated Ti on which PBS was immobilized
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SHED-CM on Ti discs increased. The amount of pro-
tein from SHED-CM increased the in P-CM groups, al-
though the surface area of Ti discs with immobilized
SHED-CM was similar for N-CM and P-CM groups.
These observations suggest that the immobilized pro-
tein was stratified on Ti discs. Taken together, these re-
sults show that there was no difference in surface area
in those groups exhibiting cell attachment (N-CM and
P-CM groups); however, the amount of SHED-CM
immobilized on the Ti surface was greater in the P-CM
groups.
The results of the in vivo study demonstrate that the
Ti implants in the P-CM groups promotes bone mor-
phogenesis around the implant surface at 4 and 8 weeks
after implantation. Ti implants are placed mainly in con-
tact with trabecular bone; knowledge of the mechanical
properties of the trabecular bone may enhance our fun-
damental understanding of the cause of the higher fail-
ure rates in poor quality bone [56]. Therefore, we chose
trabecular bone to evaluate bone regeneration around Ti
implants in this study. These results suggest that the Ti
implant treated with APP and SHED-CM had higher
osteoconducivity than other implant groups. This was
likely due to the effect of Ca-P components and the
ECM proteins such as type I collagen, fibronectin, and
decorin that are immobilized on the Ti implant. Ca-Phas been used for implant surface modification because
of its strong resemblance to the inorganic phase of the
bone matrix. Ca-P has been reported to improve osteo-
genic cell attachment [57], enhance osteoblast differenti-
ation [58], and stimulate intracellular signaling pathways
of osteoblast as well as calcium sensing receptors
(CaSRs) [59, 60]. Additionally, Ca-P is used for implant
surface modification with type I collagen, fibronectin,
other ECM proteins, and RGD peptide. The collagen
works as a scaffold for MSCs, and influences adhesion,
migration, and differentiation of these MSCs [56]. Fibro-
nectin and RGD peptide increase the number of adsorbed
MSCs and assist in early-stage cell differentiation [23, 28].
A recent study showed that implants coated with HA and
type I collagen display greater ability to stimulate new
bone formation than those treated with HA or type I col-
lagen alone [61]. In addition, histological analysis showed
that BAFO was already higher in the P-CM than the N-
PBS and P-PBS groups from 4 weeks after implantation.
These results showed greater bone morphogenesis at
places distant from the implant interface. We could not
demonstrate that BIC and BAFO were significantly higher
in P-CM groups than in P-PBS groups at 8 weeks post-
implantation. From the standpoint of animal protection
we were not able to show statistical significance without
increasing the number of experiments. However, BIC and
BAFO tended to show increased P-CM groups relative to
Fig. 7 Histological analysis around the Ti implant in vivo. In vivo bone morphogenesis around Ti implants as observed under × 100 magnification
at 4 weeks after implantation (a–d) and 8 weeks after implantation (e–h). (a, e) N-PBS implants, (b, f) P-PBS implants, (c, g) N-CM implants, (d, h)
P-CM implants. Bar indicates 100 μm. Average histomorphometric values of bone implant contact (BIC) (i) and bone area fraction occupancy
(BAFO) (j). Data are presented as mean ± SD (n = 3) for panels (i) and (j). *P < 0.05, **P < 0.01. N-CM plasma-untreated Ti on which SHED-CM was
immobilized, N-PBS plasma-untreated Ti on which PBS was immobilized, P-CM Plasma-treated Ti on which SHED-CM was immobilized, P-PBS
Plasma-treated Ti on which PBS was immobilized
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micro-CT results and histological images support this ten-
dency. In cell attachment assays, it was not revealed
whether APP treatment significantly improved cell attach-
ment between N-CM and P-CM groups. It may be sug-
gested that the surface area of immobilized SHED-CM is
not significantly higher in P-PBS groups than in N-CM
groups; however, there was an increased amount of pro-
tein from SHED-CM on Ti discs. A previous report
showed that the Ti implant treated with DMEM only had
lower osteogenesis compared to BMSC-CM, but had
higher osteogenesis than the control [32].
It is difficult to conclude whether inorganic or organic
molecules are the main contributor to osteogenesis
stimulation around the Ti implant. This is the first re-
port that focused on inorganic molecules from SHED-CM to regenerate bone. In a previous report, we com-
pared the osteogenic potential of BMSCs and SHED
[36]. We found that osteogenic gene expression was
significantly elevated in SHED compared to BMSCs.
Further, we found that the BMP signaling pathway was
important for bone formation [36]. Further studies are
required to determine the primary protein needed to
achieve high osteoconductivity in SHED-CM. In addition,
studies are needed to compare bone morphogenesis be-
tween SHED-CM and BMSC-CM. These results suggest
the potential for a new type of implant that has high
osteoconductive ability. In the future, these highly osteo-
conductive implants could potentially be used to promote
osteogenesis for advanced alveolar bone loss without an
extra operation on bone regeneration using bone pros-
thetic materials.
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Our results showed that APP treatment promoted the
immobilization of Ca-P components and ECM proteins
derived from SHED-CM onto TiO2. Therefore, Ti im-
plants treated with APP and SHED-CM promoted bone
morphogenesis not only around the implant interface,
but also at distant locations from the implant surface
during the early stages of osseointegration. Our results
suggest that immobilizing SHED-CM by using APP
treatment may be used as an effective application to fa-
cilitate bone regeneration around dental implants.
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